159 related articles for article (PubMed ID: 29956442)
1. An online self-test added to colorectal cancer screening can increase the effectiveness of familial cancer risk assessment without increasing distress.
van Erkelens A; Sie AS; Spanier MBW; van Kouwen M; Visser A; Prins JB; Hoogerbrugge N
Colorectal Dis; 2018 Oct; 20(10):897-904. PubMed ID: 29956442
[TBL] [Abstract][Full Text] [Related]
2. Online self-test identifies women at high familial breast cancer risk in population-based breast cancer screening without inducing anxiety or distress.
van Erkelens A; Sie AS; Manders P; Visser A; Duijm LE; Mann RM; Ten Voorde M; Kroeze H; Prins JB; Hoogerbrugge N
Eur J Cancer; 2017 Jun; 78():45-52. PubMed ID: 28412588
[TBL] [Abstract][Full Text] [Related]
3. Adding familial risk assessment to faecal occult blood test can increase the effectiveness of population-based colorectal cancer screening.
Dekker N; van Rossum LG; Van Vugt-van Pinxteren M; van Stiphout SH; Hermens RP; van Zelst-Stams WA; van Oijen MG; Laheij RJ; Jansen JB; Hoogerbrugge N
Eur J Cancer; 2011 Jul; 47(10):1571-7. PubMed ID: 21367600
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of an online family history tool for identifying hereditary and familial colorectal cancer.
Kallenberg FGJ; Aalfs CM; The FO; Wientjes CA; Depla AC; Mundt MW; Bossuyt PMM; Dekker E
Fam Cancer; 2018 Jul; 17(3):371-380. PubMed ID: 28936633
[TBL] [Abstract][Full Text] [Related]
5. Colorectal screening using the immunochemical faecal occult blood test kit among the Malaysian cohort participants.
Abdullah N; Abd Jalal N; Ismail N; Kamaruddin MA; Abd Mutalib NS; Alias MR; Mazlan L; Sagap I; Jamal R
Cancer Epidemiol; 2020 Apr; 65():101656. PubMed ID: 31923638
[TBL] [Abstract][Full Text] [Related]
6. Evaluating the effects of a risk-adapted screening program for familial colorectal cancer in individuals between 25 and 50 years of age: study protocol for the prospective population-based intervention study FARKOR.
Hoffmann S; Crispin A; Lindoerfer D; Sroczynski G; Siebert U; Mansmann U; Consortium F
BMC Gastroenterol; 2020 May; 20(1):131. PubMed ID: 32370777
[TBL] [Abstract][Full Text] [Related]
7. Psychosocial consequences of receiving false-positive colorectal cancer screening results: a qualitative study.
Toft EL; Kaae SE; Malmqvist J; Brodersen J
Scand J Prim Health Care; 2019 Jun; 37(2):145-154. PubMed ID: 31079520
[No Abstract] [Full Text] [Related]
8. Validation of an online questionnaire for identifying people at risk of familial and hereditary colorectal cancer.
Kallenberg FG; IJspeert JE; Bossuyt PM; Aalfs CM; Dekker E
Fam Cancer; 2015 Sep; 14(3):401-10. PubMed ID: 25800523
[TBL] [Abstract][Full Text] [Related]
9. Psychological effects of colorectal cancer screening: Participants
Kirkøen B; Berstad P; Botteri E; Bernklev L; El-Safadi B; Hoff G; de Lange T; Bernklev T
World J Gastroenterol; 2016 Nov; 22(43):9631-9641. PubMed ID: 27920484
[TBL] [Abstract][Full Text] [Related]
10. Revised Australian national guidelines for colorectal cancer screening: family history.
Jenkins MA; Ait Ouakrim D; Boussioutas A; Hopper JL; Ee HC; Emery JD; Macrae FA; Chetcuti A; Wuellner L; St John DJB
Med J Aust; 2018 Nov; 209(10):455-460. PubMed ID: 30359558
[TBL] [Abstract][Full Text] [Related]
11. Population-based screening for colorectal cancer using an immunochemical faecal occult blood test: a comparison of two invitation strategies.
Van Roosbroeck S; Hoeck S; Van Hal G
Cancer Epidemiol; 2012 Oct; 36(5):e317-24. PubMed ID: 22560885
[TBL] [Abstract][Full Text] [Related]
12. Colorectal cancer screening in first-degree relatives of colorectal cancer: participation, knowledge, and barriers against screening.
Gimeno García AZ; Quintero E; Nicolás Pérez D; Hernández M; JiménezSosa A
Eur J Gastroenterol Hepatol; 2011 Nov; 23(12):1165-71. PubMed ID: 21989122
[TBL] [Abstract][Full Text] [Related]
13. Changes in the choice of colorectal cancer screening tests in primary care settings from 7,845 prospectively collected surveys.
Wong MC; John GK; Hirai HW; Lam TY; Luk AK; Ching JY; Ng SS; Chan FK; Griffiths SM; Sung JJ
Cancer Causes Control; 2012 Sep; 23(9):1541-8. PubMed ID: 22836914
[TBL] [Abstract][Full Text] [Related]
14. [Can an online risk assessment tool for identification of hereditary colorectal cancer reach the at-risk population and influence screening compliance?].
Schürmanns K; Gelos M; Felder G; Schneider R; Möslein G
Dtsch Med Wochenschr; 2014 May; 139(18):935-40. PubMed ID: 24760714
[TBL] [Abstract][Full Text] [Related]
15. Use of Family History and Genetic Testing to Determine Risk of Colorectal Cancer.
Kastrinos F; Samadder NJ; Burt RW
Gastroenterology; 2020 Jan; 158(2):389-403. PubMed ID: 31759928
[TBL] [Abstract][Full Text] [Related]
16. Positive family history of colorectal cancer in a general practice setting [FRIDA.Frankfurt]: study protocol of a of a cross-sectional study.
Siebenhofer A; Plath J; Taubenroth M; Singer S; Hechtner M; Dahlhaus A; Rauck S; Schulz-Rothe S; Koné I; Gerlach FM
BMC Cancer; 2015 Aug; 15():605. PubMed ID: 26314581
[TBL] [Abstract][Full Text] [Related]
17. Hereditary colorectal cancer syndromes: American Society of Clinical Oncology Clinical Practice Guideline endorsement of the familial risk-colorectal cancer: European Society for Medical Oncology Clinical Practice Guidelines.
Stoffel EM; Mangu PB; Gruber SB; Hamilton SR; Kalady MF; Lau MW; Lu KH; Roach N; Limburg PJ; ;
J Clin Oncol; 2015 Jan; 33(2):209-17. PubMed ID: 25452455
[TBL] [Abstract][Full Text] [Related]
18. What influences the decision to participate in colorectal cancer screening with faecal occult blood testing and sigmoidoscopy?
van Dam L; Korfage IJ; Kuipers EJ; Hol L; van Roon AH; Reijerink JC; van Ballegooijen M; van Leerdam ME
Eur J Cancer; 2013 Jul; 49(10):2321-30. PubMed ID: 23571149
[TBL] [Abstract][Full Text] [Related]
19. Decentralized colonoscopic surveillance with high patient compliance prevents hereditary and familial colorectal cancer.
Sjöström O; Lindholm L; Tavelin B; Melin B
Fam Cancer; 2016 Oct; 15(4):543-51. PubMed ID: 26935832
[TBL] [Abstract][Full Text] [Related]
20. Are anxiety levels associated with the decision to participate in a Swedish colorectal cancer screening programme? A nationwide cross-sectional study.
Wangmar J; von Vogelsang AC; Hultcrantz R; Fritzell K; Wengström Y; Jervaeus A
BMJ Open; 2018 Dec; 8(12):e025109. PubMed ID: 30580275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
